Taking A Small Position In Amcor (NYSE:AMCR)

Luis Alvarez I have a terrible confession to make, dear readers: I’m ageing. It’s as much of a shock to me as it is to thee. Anyway, among the behavioural changes such unpleasantness demands is a slight change to my investment philosophy. I’m now focusing on buying dividend paying stocks, and I’ll be limiting myself…

Read More

Keep Adding To Your Altria Position (NYSE:MO)

FotografiaBasica Altria Group, Inc. (NYSE:MO) is a major tobacco company with a market capitalization of less than $80 billion. The company has had struggles with e-cigarettes, spending many billions of dollars on Juul, but it’s continued to run a well-operated business with reliable cash flow. The company’s dividends and reliable business improvements make it a…

Read More

Five9 Stock: Good Position To Capture AI Contact Center Tailwinds (NASDAQ:FIVN)

fizkes/iStock via Getty Images Five9 (NASDAQ:FIVN) is a cloud contact center software (CCaaS) provider that empowers businesses to manage customer interactions through the cloud. They offer a suite of features including call center functionality, omnichannel communication, and customer analytics. FIVN went public in 2014, with an initial share price of $7.6. Since its IPO, the…

Read More

Canadian Net REIT (NET.UN:CA): Our Largest REIT Position

hapabapa/iStock Editorial via Getty Images Points to note: 1) All values are in CAD unless noted otherwise. 2) Prior to June 17, 2021, Canadian Net operated under the name of Fronsac Real Estate Investment Trust (FRO.UN). Previous Coverage We covered the 2023-Q1 results of Canadian Net Real Estate Investment Trust (TSXV:NET.UN:CA) and came away impressed…

Read More

Coya Therapeutics: Interesting Early Data In CNS Diseases, Very Low Cash Position (COYA)

BlackJack3D Coya Therapeutics (NASDAQ:COYA) targets inflammation by modulating the function of regulatory T cells (Tregs) in neurological diseases. The “original” lead asset used to be COYA 101, an autologous regulatory T-cell product candidate with a completed Phase 2a trial in Amyotrophic Lateral Sclerosis under its belt. The trial was completed way back in 2022. However,…

Read More

Frontline: Top 2024 Long Position (NYSE:FRO)

taikrixel Frontline (NYSE:FRO) (up 89% year-to-date) has vastly outperformed the S&P and is still my top long position going into 2024. The tanker market has been supported by a significant figure of oil in transit or barrels at sea since the end of 2021. As the buildup in land oil inventories after the 2020 Covid-19…

Read More

Axcelis Technologies: Closing The Short Position (NASDAQ:ACLS)

William_Potter Investment Thesis I covered Axcelis Technologies (NASDAQ:ACLS) two months ago with this article and explained how the company and the semiconductor industry had been more resilient than most people had thought. Axcelis has a crucial position in the industry, providing ion implantation equipment to chip manufacturers. While it performs strongly in good times, it…

Read More

Zscaler: Competitive Position Remains Strong (NASDAQ:ZS)

Dragos Condrea/iStock via Getty Images Investment Thesis I covered Zscaler, Inc. (NASDAQ:ZS) earlier in July, in which I covered ZS’s competitive position in the market. In this article, I will cover some recent developments, including the company’s recent results and Microsoft Corporation’s (MSFT) entry into the market. I firmly believe that Zscaler’s platform offers superior…

Read More

Crypto.com Teams Up with PayPal and Paxos to Boost PYUSD Position

Despite entering the list of approved digital assets, PayPal’s PYUSD stablecoin may not experience the instantaneous adoption initially anticipated following the launch.  Crypto.com, a Singapore-based digital assets trading platform, has formed a strategic alliance with PayPal and Paxos to strengthen its global standing as the preferred exchange for the PayPal stablecoin PYUSD. The move builds…

Read More

On Holding: Consider Holding Your Position (NYSE:ONON)

PeopleImages/iStock via Getty Images On Holding AG (NYSE:ONON) is an innovative company in athletic footwear that was incorporated in Switzerland (2010) and then listed in the NYSE (2021). The company engages its activities in the running segment with a competitive advantage in its patented cushioned platform technology called CloudTec. In 2022, On Holding reached $1.3…

Read More

Microsoft Is Gradually Closing In on Apple as It Eyes Position as World’s Largest Stock

Although hundreds of billions away, Microsoft’s valuation is gradually closing in on that of Apple, racing to become the world’s largest. Microsoft Corporation (NASDAQ: MSFT) is making progress with its valuation and seems ready to give Apple Inc (NASDAQ: AAPL) a run for its money. The company’s valuation is now moving closer to Apple’s as it races to…

Read More

Rentokil Initial: Thriving Compounder In A Market Leading Position (NYSE:RTO)

Dan Kitwood/Getty Images News Investment thesis Our current investment thesis is Rentokil Initial plc (NYSE:RTO) (OTCPK:RKLIF) is an incredibly attractive business, with a market-leading position in various essential services segments globally. This is developed through scale and deep expertise, allowing the company to create long-term relationships with clients. The company’s strategy of bolt-on M&A has…

Read More

Autodesk’s Dominant Position And ‘Switching Moat’ Prime It For Strong Returns (ADSK)

Parradee Kietsirikul/iStock via Getty Images Investment Thesis I’m of the opinion that Autodesk, Inc. (NASDAQ:ADSK) stock presents a strong buy opportunity. Autodesk has firmly established itself as a frontrunner in the digital design sector, consistently demonstrating its innovative capabilities and industry expertise. A key pillar of its success is the “switching moat” approach, which not…

Read More

Constellium: Benefiting From The Strong Market Position And Pricing Power (NYSE:CSTM)

Bet_Noire/iStock via Getty Images Constellium (NYSE:CSTM) is experiencing a downturn in revenue growth, which is driven mainly by packaging end-market weakness. However, the company is coping relatively well due to its pricing power and ability to exploit more successfully the momentum in the aerospace market. In addition, Constellium streamlined its business model in order to…

Read More

Travere Boosts Cash Position As Investors Brace For Filspari Data (NASDAQ:TVTX)

peakSTOCK/iStock via Getty Images Introduction Travere Therapeutics (NASDAQ:TVTX), a San Diego-based biopharmaceutical company, specializes in developing and delivering treatments for rare kidney, liver, and metabolic diseases. They recently received FDA accelerated approval for their lead product, sparsentan, targeting specific kidney disorders, and are also working on other treatments, including genetic disorders. Their efforts include expanding…

Read More